|
SESSIONS
-
Targeting Interleukins and Interferons
-
Developing Chemokine Antagonists
-
Leveraging Technologies for Cytokine-Based Drug Development
-
Targeting the TNF Family
-
Novel Therapeutic Targets ・Processes, Pathways and Networks
-
Therapeutic Potential of Cytokine Targets
PANELS
BREAKOUT DISCUSSIONS
-
Targeting Cytokine Interactions
-
What are the Limitations of Cytokine-Based Immunotherapies?
-
What is the Predictive Value of Cytokine Biomarkers in Autoimmune and
Inflammatory Diseases?
 |
|
Diagnosing
the Disease: Disruptive Innovation
in Healthcare
Clayton M. Christensen, DBA, Robert and Jane Cizik
Professor of Business
Administration, Harvard Business School
Disruption
of the Pharmaceutical Industry: Moving
from Products to Solutions
Elizabeth
L. Bewley, MBA, Vice President, Strategic Planning, Johnson &
Johnson Health Care Systems Inc. - Speaker
Biography
Risk
Diagnosis for Disease Prevention
C. Thomas Caskey, M.D., F.A.C.P., Director and Chief
Executive Offi cer, Brown
Foundation Institute of Molecular Medicine,
University of Texas Health Science Center |
SPEAKERS
-
Linda Burkly, Ph.D., Biogen Idec
-
Israel F. Charo, M.D., Ph.D., University of California, San Francisco
-
Vishva Dixit, Ph.D., Genentech Inc.
-
Chen Dong, Ph.D., MD Anderson Cancer Center
-
Charles E. Egwuagu, MPH, Ph.D., National Institutes of Health
-
Rafael Fernandez-Botran, Ph.D., University of Louisville
-
Simon Fricker, Ph.D., Genzyme Corporation
-
Iqbal S. Grewal, Ph.D., Seattle Genetics, Inc.
-
Thomas Hamilton, Ph.D., Cleveland Clinic
-
Wayne Hancock, Ph.D., Children痴 Hospital of Philadelphia
-
William Hipkin, Ph.D., Schering-Plough Research Institute
-
Ziwei Huang, Ph.D., University of California at San Diego
-
Sarah Hymowitz, Ph.D., Genentech
-
Sameer Kawatkar, Ph.D., Chemokine Pharmaceuticals Inc.
-
Sanjay Khare, Ph.D., ImmunGene
-
Sergei V. Kotenko, Ph.D., UMDNJ - New Jersey Medical School
-
Xiaoxia Li, Ph.D., Cleveland Clinic
-
Bailin Liang, Ph.D., Centocor
-
Fabienne Mackay, Ph.D., Garvan Institute of Medical Research
-
Christopher Moore, Ph.D., University of North Carolina at Chapel Hill
-
Wei Tong, Ph.D., University of Pennsylvania School of Medicine
-
Matthew Walters, Ph.D., ChemoCentryx
|